| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +0.86% | +1.43% | +47.17% | +163.68% | 1,067B | |
| +1.59% | +4.09% | +56.51% | +52.50% | 635B | |
| +0.95% | +1.91% | +36.30% | +82.78% | 458B | |
| +1.30% | +8.29% | +37.84% | +31.84% | 347B | |
| +1.34% | +4.40% | +37.69% | +41.62% | 295B | |
| +1.18% | +3.44% | +18.68% | +19.68% | 262B | |
| +0.78% | -1.17% | -28.15% | -39.09% | 216B | |
| +1.22% | +2.66% | +22.66% | +59.87% | 203B | |
| -1.18% | -3.70% | +11.28% | +67.52% | 161B | |
| Average | +0.59% | +1.33% | +26.66% | +53.38% | 404.83B | |
| Weighted average by Cap. | +0.53% | +1.95% | +36.31% | +79.29% |
Employees
4
Sector
Pharmaceuticals
